Consequences of HPV-6,-11,-16,-18 Vaccine in HIV Women
ID Number 00-0667-00025Principal Investigator(s)
John B. Steever
Department(s) or Division(s)
The purpose of this study is to evaluate the immunogenicity, safety, tolerability, and behavioral consequences of an HPV-6, -11, -16, -18 vaccine in HIV-infected young women.
Recruiting Patients: Yes